rAAV2/8-hCYP4V2

N/A

Report date: 2023/10/26 17:02:32

Base Information

Drug NamerAAV2/8-hCYP4V2
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCYP4V2 gene transference
TargetsCytochrome P450 4V2
Therapy Area/IndicationsBietti Crystalline DystrophyRetinal Dysplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Tongren Hospital, Cmu
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Tongren Hospital, Cmu
Inactive CompaniesN/A
Active IndicationsBietti Crystalline DystrophyRetinal Dysplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A